Changing the therapeutic landscape in non-small cell lung cancers: The evolution of comprehensive molecular profiling improves access to therapy Journal Article


Authors: Sabari, J. K.; Santini, F.; Bergagnini, I.; Lai, W. V.; Arbour, K. C.; Drilon, A.
Article Title: Changing the therapeutic landscape in non-small cell lung cancers: The evolution of comprehensive molecular profiling improves access to therapy
Abstract: Targeting genomic alterations has led to a paradigm shift in the treatment of patients with lung cancer. In an effort to better identify potentially actionable alterations that may predict response to FDA-approved and or investigational therapies, many centers have migrated towards performing targeted exome sequencing in patients with stage IV disease. The implementation of next-generation sequencing (NGS) in the evaluation of tumor tissue from patients with NSCLC has led to the discovery of targetable alterations in tumors that previously had no known actionable targets by less comprehensive profiling. An improved understanding of the molecular pathways that drive oncogenesis in NSCLC and a revolution in the technological advances in NGS have led to the development of new therapies through biomarker-driven clinical trials. This review will focus on the advances in molecular profiling that continue to fuel the revolution of precision medicine, identifying targets such as MET exon 14 skipping alterations and select recurrent gene alterations with increasing frequency. © 2017, Springer Science+Business Media New York.
Keywords: targeted therapy; molecular diagnostics; precision medicine; rna sequencing; next-generation sequencing (ngs); non-small cell lung cancer (nsclc); met exon 14 skipping alteration; ntrk fusion
Journal Title: Current Oncology Reports
Volume: 19
Issue: 4
ISSN: 1523-3790
Publisher: Springer  
Date Published: 2017-04-01
Start Page: 24
Language: English
DOI: 10.1007/s11912-017-0587-4
PROVIDER: scopus
PUBMED: 28303491
PMCID: PMC6428198
DOI/URL:
Notes: Review -- Export Date: 2 May 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon
  2. Joshua K Sabari
    36 Sabari
  3. Kathryn Cecilia Arbour
    88 Arbour
  4. Wei-Chu Victoria Lai
    59 Lai
  5. Fernando Costa Santini
    22 Santini